Recently, it was reported that CD40 activation on macrophages released interferon-γ and CCL2 and induced MMP-dependent fibrosis degradation in pancreatic carcinoma, resulting in the enhanced chemotherapy efficacy [39, 58]. The gene discussed is CCL2; the disease is exocrine pancreatic carcinoma.